Neuralstem Awarded Department of Defense Contract for Brain Cancer Research

The US Department of Defense has contracted Neuralstem Inc, to develop its human neural stem cell technology for the treatment of cancerous brain tumors. Neuralstem, known for its extensive work in ALS, will be awarded $1.6 million for the first year of this contract. The program has the ambitious goal of having a therapeutic product for the treatment of cancerous brain tumors ready to submit to the FDA by the end of 2015.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail